Insider Transactions in Q1 2020 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q1 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2020
|
Nadim Ahmed EVP and President, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct |
17,204
+34.25%
|
-
|
|
Mar 01
2020
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,470
-23.39%
|
$617,730
$59.06 P/Share
|
|
Mar 01
2020
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,579
+35.44%
|
-
|
|
Mar 01
2020
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
8,923
-18.55%
|
$526,457
$59.06 P/Share
|
|
Mar 01
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
23,349
+32.68%
|
-
|
|
Feb 04
2020
|
Nadim Ahmed EVP and President, Hematology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,071
-6.34%
|
$68,544
$64.29 P/Share
|
|
Feb 04
2020
|
Nadim Ahmed EVP and President, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct |
2,076
+10.94%
|
-
|
|
Feb 04
2020
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-4.49%
|
$74,432
$64.29 P/Share
|
|
Feb 04
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
3,592
+12.17%
|
-
|